In-vitro cytotoxic evaluation of newly designed ciprofloxacin-oxadiazole hybrids against human liver tumor cell line (Huh7)

Pak J Pharm Sci. 2021 May;34(3(Supplementary)):1143-1148.

Abstract

Fluoroquinolones are targets of interest due to their broad spectrum antibacterial activity. Structure-activity relationship (SAR) of fluoroquinolones clearly indicates that substitution at C-7 position enhances the lipophilicity of these scaffolds resultantly affording pharmacologically significant compounds. Therefore, various ciprofloxacin-oxadiazole hybrids were synthesized and characterized by spectral analysis. Cytotoxic activity of these derivatives was assessed using human liver tumor cells (Huh7). One dose anticancer test results revealed moderate cytotoxicity of the newly synthesized compounds against this cell line. As the only compound 4a depicted comparatively lower cell viability value (81.91% using 100μg/mL concentration) than the other compounds.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Carcinoma, Hepatocellular / pathology*
  • Cell Line, Tumor
  • Cell Survival / drug effects*
  • Ciprofloxacin / analogs & derivatives
  • Ciprofloxacin / chemical synthesis
  • Ciprofloxacin / pharmacology*
  • Drug Screening Assays, Antitumor
  • Humans
  • In Vitro Techniques
  • Liver Neoplasms / pathology*
  • Magnetic Resonance Spectroscopy
  • Oxadiazoles / chemical synthesis
  • Oxadiazoles / pharmacology*

Substances

  • Antineoplastic Agents
  • Oxadiazoles
  • Ciprofloxacin